Cigna Corp (CGN.BE)
| Previous close | 301.10 |
| Open | 300.90 |
| Bid | 293.05 x 0 |
| Ask | 295.20 x 0 |
| Day's range | 293.50 - 301.10 |
| 52-week range | 236.90 - 340.15 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
The Cigna Group's Second Quarter 2024 Earnings Release Details
Global health company The Cigna Group (NYSE:CI) will release its second quarter 2024 financial results on Thursday, August 1, 2024, and will host a conference call the same day.
- PR Newswire
Express Scripts by Evernorth Members Paid Less for Prescriptions in 2023 Despite Drug Price Increases
Express Scripts, the pharmacy benefits services business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today released research spotlighting that members with employer-provided coverage paid less at the pharmacy counter for prescription drugs in 2023 compared to the previous year. On average, members with employer-sponsored drug coverage paid $15.10 out-of-pocket for a 30-day prescription in 2023, a decrease of about 1% compared to 2022. While drug manufacturers raised prices for 60%
- PR Newswire
Express Scripts enhances strategies to support access to care at independent pharmacies
Express Scripts, the pharmacy benefits services business of The Cigna Group's (NYSE: CI) Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies. This new collaboration with CPESN® USA, a network of pharmacy providers that deliver health services, is a direct result of guidance from the organization's Independent Pharmacy Advisory Committee, which includes 38 pharmacists from all regions of the United States and is led by former independent
